Skip to main content

Table 3 Doxycycline study - comparisons of enrollment and follow-up assessments*

From: Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy – the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial

Endpoint

N

Enrollment

Mean (SD)

Follow-up

Mean (SD)

Paired T-test

p-value

Body Mass Index (kg/m2)

6

25.41 (4.41)

26.07 (4.45)

0.080

6 Minute Walk Test (feet)

5

1142 (159)

1283 (194)

0.110

St. George’s Respiratory Questionnaire – total score

6

50.90 (8.38)

18.40 (6.39)

0.002

FVC percent predicted (%)

6

61.38 (10.65)

67.67 (14.39)

0.311

MMP9 activity

6

6.19 (2.04)

2.59 (0.66)

0.006

MMP3 activity

6

9.03 (2.02)

4.83 (3.54)

0.041

MMP9 expression

6

3.39 (1.06)

1.45 (0.41)

0.004

TIMP-1 expression

6

5.28 (1.56)

2.72 (0.67)

0.018

VEGF expression

6

9.03 (2.02)

4.83 (3.54)

0.041

  1. *Data are taken from [15]. Activities levels are determined from Western Blot. See [15] for more details